Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117438) titled 'Efficacy and Safety of Nebulized Human MSC-Exosomes in Severe Dry Eye Disease' on Jan. 23.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Wenzhou Medical University Affiliated Eye and Vision Hospital
Condition:
Severe dry eye disease
Intervention:
Cyclosporine group:Sodium hyaluronate eye drops qid + Cyclosporine eye drops bid
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-23
Target Sample Size: Cyclosporine group:20;Experimental group:20;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=3062...